Martin Reese has joined the scientific advisory board of GenMatrix of Oakland, Calif. Reese, a co-founder of Neomorphic and former chief scientific officer there, currently serves as director of informatics discovery for the European-American company ValiGen. Reese was also a member of the Berkeley Drosophila Genome Project and had been part of Lawrence Berkeley National Laboratory’ s team that helped develop gene-finding algorithms for the Human Genome Project.
Mark Gurney has joined deCode Genetics of Reykjavik, Iceland, as vice president for target discovery where he will oversee development of downstream value and products using deCode’ s disease-gene research. The target discovery group will incorporate the work of deCode’ s functional genomics department and help expand the company’ s drug development activities. Most recently, he had been director of genomics research at Pharmacia.
Alexander Kel is now vice president research and development at gene regulation information provider Biobase of Braunschweig, Germany. Kel, who has published more than 75 scientific papers, had been a researcher at the Russian Academy of Sciences’ Institute of Cytology and Genetics in Novosibirsk, Russia. Olga Kel-Margoulis has also joined the company and will maintain the Compel database on composite regulatory elements within gene regulatory regions and develop methods for the recognition of composite elements in genomic contexts.
TissueInformatics of Pittsburgh, Pa., has hired bioinformatics scientist Xiaoping Su, formerly a bioinformatics analyst with OSI Pharmaceuticals of Uniondale, NY.